TEKTROTYD Kit for radiopharmaceutical preparation Ref.[11075] Active ingredients: Technetium ⁹⁹ᵐTc hynic-octreotide

Publisher: ROTOP Pharmaka GmbH, Bautzner Landstrasse 400, 01328 Dresden, Germany, Phone: +49 351 26 31 02 10, Fax: +49 351 26 31 03 13, e-mail: service@rotop-pharmaka.de

Product name and form

TEKTROTYD 16 micrograms kit for radiopharmaceutical preparation.

Pharmaceutical Form

Kit for radiopharmaceutical preparation.

White or almost white lyophilisates.

For radiolabelling with sodium pertechnetate (99mTc) solution.

Qualitative and quantitative composition

Vial I contains 16 µg of HYNIC-[D-Phe1, Tyr3-octreotide] TFA salt.

Vial II contains 10 mg of EDDA (Etylenediamine-N,N'-diacetic acid).

For a full list of excipients, see section 6.1.

The radionuclide is not part of the kit.

Active Ingredient Description
Technetium ⁹⁹ᵐTc hynic-octreotide

Technetium ⁹⁹ᵐTc hynic-octreotide is for diagnostic use only. Technetium (99mTc) labelled EDDA/HYNIC-TOC binds with high affinity to somatostatin receptor subtypes 2 and 5, also to subtype 3 but with lesser affinity.

List of Excipients

Vial I:

Tricine (N-[tris(hydroxymethyl)methyl]glycine)
Stannous chloride dihydrate
Mannitol
Nitrogen (as protective gas)

Vial II:

Disodium hydrogen phosphatedodecahydrate
Sodium hydroxide
Nitrogen (as protective gas)

Pack sizes and marketing

Glass vials (Type I Ph. Eur.) of 10 mL nominal capacity, sealed with a rubber stopper and an aluminium cap with flip off seal.

Vials I and II contain components for the radiopharmaceutical preparation of 99mTcEDDA/HYNIC-TOC.

Each vial contains a white or nearly white lyophilisate for preparation of a solution for injection.

Vial I: active substance: HYNIC-[D-Phe1, Tyr3octreotide] TFA salt, excipients: stannous chloride dihydrate, tricine (N[Tris(hydroxymethyl)methyl]glycine), mannitol, nitrogen

Vial II: active substance: EDDA (ethylenediamine-N,N'-diacetic acid), excipients: disodium hydrogen phosphate dodecahydrate, sodium hydroxide, nitrogen

Pack size: 2 vials.

Marketing authorization holder

ROTOP Pharmaka GmbH, Bautzner Landstrasse 400, 01328 Dresden, Germany, Phone: +49 351 26 31 02 10, Fax: +49 351 26 31 03 13, e-mail: service@rotop-pharmaka.de

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.